New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
New insights into colorectal cancer and E. coli

New insights into colorectal cancer and E. coli

by Béatrice St-Cyr-Leroux,University of MontrealclbA and bft detection. a clbA and b bft presence in DNA extracted from fecal samples were detected using conventional qualitative PCR. M: marker;
Oncology December 17,2023
New insights into colorectal cancer and E. coli

New insights into colorectal cancer and E. coli

by Béatrice St-Cyr-Leroux,University of MontrealclbA and bft detection. a clbA and b bft presence in DNA extracted from fecal samples were detected using conventional qualitative PCR. M: marker;
Oncology December 17,2023
Nectin-4 is widely expressed in head and neck squamous cell carcinoma

Nectin-4 is widely expressed in head and neck squamous cell carcinoma

by Impact Journals LLCNectin-4 immunohistochemistry in HNSCC. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28299Nectin-4 has been successfully established as a target molecule in loca
World medicine December 17,2023
Nectin-4 is widely expressed in head and neck squamous cell carcinoma

Nectin-4 is widely expressed in head and neck squamous cell carcinoma

by Impact Journals LLCNectin-4 immunohistochemistry in HNSCC. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28299Nectin-4 has been successfully established as a target molecule in loca
World medicine December 17,2023
Racial disparity in pro-metastatic tumor microenvironment among women with residual breast cancer after NAC

Racial disparity in pro-metastatic tumor microenvironment among women with residual breast cancer after NAC

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResidual tumors from Black patients with estrogen receptor (ER)-positive/HER2-negative primary breast cancer treated w
Oncology December 17,2023
Racial disparity in pro-metastatic tumor microenvironment among women with residual breast cancer after NAC

Racial disparity in pro-metastatic tumor microenvironment among women with residual breast cancer after NAC

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResidual tumors from Black patients with estrogen receptor (ER)-positive/HER2-negative primary breast cancer treated w
Oncology December 17,2023
Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some

Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAdding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median overall survival (OS) t
Oncology December 17,2023
Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some

Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAdding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median overall survival (OS) t
Oncology December 17,2023
MRI-guided radiotherapy produces fewer side effects, better quality of life for patients with localized prostate cancer

MRI-guided radiotherapy produces fewer side effects, better quality of life for patients with localized prostate cancer

byUniversity of California, Los AngelesCredit: CC0 Public DomainFor men who undergo radiotherapy for localized prostate cancer, the precise targeting capabilities of MRI guidance resulted in few
World medicine December 17,2023
MRI-guided radiotherapy produces fewer side effects, better quality of life for patients with localized prostate cancer

MRI-guided radiotherapy produces fewer side effects, better quality of life for patients with localized prostate cancer

byUniversity of California, Los AngelesCredit: CC0 Public DomainFor men who undergo radiotherapy for localized prostate cancer, the precise targeting capabilities of MRI guidance resulted in few
World medicine December 17,2023
Moderna's experimental cancer vaccine treats but doesn't prevent melanoma—a biochemist explains how it works

Moderna's experimental cancer vaccine treats but doesn't prevent melanoma—a biochemist explains how it works

by Mark R. O'Brian,The ConversationCredit: Pixabay/CC0 Public DomainMediaoutletshave reported the encouraging findings of clinical trials for a new experimental vaccine developed
Oncology December 17,2023
Moderna's experimental cancer vaccine treats but doesn't prevent melanoma—a biochemist explains how it works

Moderna's experimental cancer vaccine treats but doesn't prevent melanoma—a biochemist explains how it works

by Mark R. O'Brian,The ConversationCredit: Pixabay/CC0 Public DomainMediaoutletshave reported the encouraging findings of clinical trials for a new experimental vaccine developed
Oncology December 17,2023
MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

by Impact Journals LLCEvaluation of the toxicity of MK256 in vivo. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28305A new research paper titled "MK256 is a novel CDK8 inhibitor
Oncology December 17,2023
MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

by Impact Journals LLCEvaluation of the toxicity of MK256 in vivo. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28305A new research paper titled "MK256 is a novel CDK8 inhibitor
Oncology December 17,2023
MicroRNA can help predict which breast cancer patients are more likely to see their cancer come back

MicroRNA can help predict which breast cancer patients are more likely to see their cancer come back

byAmerican College of SurgeonsCredit: Pixabay/CC0 Public DomainMicroRNA (miRNA) can be used as a biomarker to predict which patients are likely to face breast cancer recurrence and mortality, ac
World medicine December 17,2023
MicroRNA can help predict which breast cancer patients are more likely to see their cancer come back

MicroRNA can help predict which breast cancer patients are more likely to see their cancer come back

byAmerican College of SurgeonsCredit: Pixabay/CC0 Public DomainMicroRNA (miRNA) can be used as a biomarker to predict which patients are likely to face breast cancer recurrence and mortality, ac
World medicine December 17,2023
Ectopic expression of lncRNA MVIH as a potential diagnostic biomarker in cervical cancer

Ectopic expression of lncRNA MVIH as a potential diagnostic biomarker in cervical cancer

by Impact JournalsExpression of lncRNA MVIH in CC tumor as compared to marginal non-tumor tissues. Credit:Genes & Cancer(2022). DOI: 10.18632/genesandcancer.224A new research paper was
Oncology December 17,2023
Ectopic expression of lncRNA MVIH as a potential diagnostic biomarker in cervical cancer

Ectopic expression of lncRNA MVIH as a potential diagnostic biomarker in cervical cancer

by Impact JournalsExpression of lncRNA MVIH in CC tumor as compared to marginal non-tumor tissues. Credit:Genes & Cancer(2022). DOI: 10.18632/genesandcancer.224A new research paper was
Oncology December 17,2023
KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer

KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer

by Nanjing University School of Life SciencesGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI153470KRAS is one of the most frequently activated oncogene
World medicine December 17,2023
KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer

KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer

by Nanjing University School of Life SciencesGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI153470KRAS is one of the most frequently activated oncogene
World medicine December 17,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com